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The roles of individual bacteria and their relationship in the development of colorectal cancer (CRC) 
remain unclear. We aimed to determine the prevalence of CRC‑associated bacteria using quantitative 
real‑time PCR (qPCR) or 16S rRNA analysis and the statistical correlations of patient demographics 
and clinical characteristics comprising alcohol consumption with CRC‑associated bacteria. We 
determined the prevalence of five CRC‑associated bacterial species in 38 CRC patients (39 samples) 
and 21 normal individuals using qPCR, and the relative abundance of bacterial taxa in the gut 
microbiome was assessed using 16S rRNA analysis. Fusobacterium nucleatum was the only bacterium 
that was significantly (P < 0.0001) more prevalent in the cancer tissue (82.1%) than in the normal tissue 
(0%) by qPCR. 16S rRNA analysis showed a significant correlation between six operational taxonomic 
units (OTUs), namely, the genera Fusobacterium, Peptostreptococcus, Collinsella, Prevotella, 
Parvimonas, and Gemella, in patients with CRC. An integrated analysis using 16S rRNA data and 
epidemiological characteristics showed that alcohol consumption was significantly correlated with 
the abundance of Fusobacterium OTUs. The correlation of alcohol consumption with the abundance 
of Fusobacterium OTUs in cancer tissue discovered using 16S rRNA analysis suggests a possible link 
between alcohol metabolism and subsequent tumorigenesis caused by F. nucleatum.
Colorectal cancer (CRC) is the third most common cancer type in men and the second most common in women 
worldwide, and it is the fourth leading cause of cancer-related deaths in the  world1. The mechanisms underly-
ing the development of CRC are not comprehensively understood; however, various risk factors are known to 
contribute to carcinogenesis in CRC, including age, presence of colon polyps, high consumption of red meat, 
obesity, smoking, and alcohol  consumption2. Furthermore, the response to these risk factors seems to differ 
between ethnicities and geographical regions, which may affect the prevalence and prognosis of CRC.
Recently, the gut microbiota has been added to the list of CRC risk factors, as it has been implicated in the 
development of CRC and might contribute to CRC progression, as suggested by the dynamic “driver-passenger” 
 model3. In the past few decades, it has been shown that among the diverse bacterial species that are a part of the 
gut microbiome, the presence of specific bacteria can play a role in colorectal  carcinogenesis4. Bacteria-driven 
oncogenic mechanisms in CRC have been proposed to include the activation of Wnt signaling (enterotoxigenic 
Bacteroides fragilis (ETBF)5 and Fusobacterium  species6), proinflammatory signaling (Enterococcus faecalis7 and 
Streptococcus gallolyticus8), and genotoxicity (colibactin-producing Escherichia coli, colB + E. coli9). These carci-
nogenic effects can occur from very early stages and over the multistep processes of CRC carcinogenesis and can 
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be accompanied by shifts in the gut microbiome and  metabolome10. Furthermore, a recent study showed that 
the gut microbiome may promote the progression of CRC 11. Therefore, it is crucial to identify bacteria that may 
be associated with the development of CRC and to assess which other factors can elicit transformation from a 
healthy gut microbiome to a tumorigenic microenvironment.
Diet is the most well-known factor that influences the gut microbiome, and differences in diet can substan-
tially affect the entire gut  microenvironment12. In South Korea, CRC is one of the most prevalent types of cancer; 
however, few metagenomic studies have been conducted to determine the association between the gut microbi-
ome and CRC  development13. The composition of the gut microbiome may be influenced by factors other than 
diet, including alcohol  consumption14. Numerous epidemiological studies have shown that alcohol consumption 
is strongly associated with the incidence of CRC 15. Retrospective propensity score matching analysis (adjusted 
hazard ratio: 1.86) revealed that high alcohol consumption increased the development of CRC 16. Alcohol con-
sumption is considerably high in South  Korea17 and may be a causative factor underlying the high prevalence of 
CRC in  Korea18. However, to our knowledge, the effect of alcohol consumption on the gut microbiome has not 
been investigated thoroughly in South Korea.
In this study, we aimed to determine the prevalence of five CRC-associated bacteria (ETBF, E. faecalis, 
colB + E. coli, F. nucleatum, and S. gallolyticus) in the biopsied tissues of patients with CRC using quantitative 
real-time PCR (qPCR) and the relative abundance of operational taxonomic units (OTUs) by 16S rRNA analysis. 
Furthermore, we determined the associations between the epidemiological characteristics of CRC and the gut 
microbiome and alcohol consumption.
Results
Comparison of demographics and clinical characteristics of cases and controls. A total of 39 
CRC samples and 21 control samples were examined (Table 1). No significant differences between the groups 
were observed with respect to epidemiological characteristics, apart from BMI and hypertension. BMI was 
lower in CRC patients (22.9 ± 2.9) than in controls (24.8 ± 2.7), and hypertension was more prevalent in controls 
(76.2%, n = 16/21) than in CRC patients (46.2%, n = 18/39). The CRC cases consisted of 71.8% colon cancers and 
28.2% rectal cancers, with right- and left-sided cancers accounted for 28.2% and 71.8% of the cases, respectively.
Prevalence of CRC‑associated bacteria as assessed by qPCR. The prevalence of the five CRC-asso-
ciated bacteria was examined in the carcinoma tissues (CTs) of CRC patients and in normal tissues (NTs) of con-
trols using qPCR (Table 2). F. nucleatum was most frequently detected in CRC patients and was not detected in 
the NTs of controls (82.1% and 0%, respectively; P < 0.0001). However, no significant difference in the prevalence 
of colB + E. coli, ETBF, E. faecalis, or S. gallolyticus was observed between CRC patients and controls.
Prevalence of F. nucleatum by tumor stage and tissue type. We analyzed the association of F. nucle-
atum positivity in CRC patients with that in controls based on clinicopathological features. Patients with CRC 
were classified by tumor stage (early stage [I/II] or late stage [III/IV]). F. nucleatum was detected very frequently 
in both early (92.3%) and late (76.9%) stages; however, this difference was not significant (Fig. 1A). With respect 
to the tissue type, the prevalence of F. nucleatum was significantly higher in CTs (82.1%) than in adjacent normal 
tissues (ATs) (39.9%) as well as distal normal tissues (DTs) (33.3%) in CRC patients; no significant difference 
was observed between ATs and DTs (Fig. 1B). When the cycle threshold (Ct) values obtained from qPCR were 
compared among tissue types in F. nucleatum-positive cases, they were found to be significantly lower in CTs 
(Mann–Whitney U test, P < 0.0001). F. nucleatum was markedly enriched in CTs compared to ATs (Supplemen-
tary Fig. S1). The fadA gene, which encodes a virulence factor implicated in adhesion and invasion, was statisti-
cally more frequent in the CTs of CRC patients (69.2%) than in the NTs of controls (9.5%) (Fig. 1C).
16S rRNA analysis. Sequencing of the V3 and V4 regions in the 16S rRNA gene produced 171,988 ± 81,412 
sequencing reads, on average. After quality filtration, clustering and taxonomy assignment were performed at 
the genus level by QIIME  software19. A total of 698 OTUs were generated and used for further statistical analy-
sis. In a diversity analysis, no significant difference in α- or β-diversity was observed between CRC cases and 
controls (Supplementary Fig. S2).
When comparing CRC cases with controls, the proportions of six OTUs, namely, Peptostreptococcus, Collin-
sella, Prevotella, Parvimonas, Fusobacterium, and Gemella, were significantly different after false discovery rate 
correction for multiple testing (Fig. 2). Among the epidemiological characteristics with continuous values, Fuso-
bacterium-positive CRC patients were significantly younger than Fusobacterium-negative patients (64.0 ± 10.5 vs. 
73.1 ± 9.3; P = 0.034), which was also true for Parvimonas-positive patients (60.4 ± 8.5 vs. 69.0 ± 10.9; P = 0.011; 
Table 3). With respect to epidemiological characteristics with binomial values, Fusobacterium was associated 
with alcohol consumption and KRAS mutation (P = 0.088 and P = 0.094), and Parvimonas was associated with 
tumor location and KRAS mutation, although the difference was only marginally significant (P = 0.070, Table 4). 
Fusobacterium was observed in 14 of the 15 heavy drinkers (93.3%) but not in 11 of the 17 non/light drink-
ers (64.7%). The proportion of Fusobacterium OTUs was significantly higher in heavy drinkers than in non/
light drinkers (P = 0.003); no corresponding pattern was observed in controls (Fig. 3). With respect to tumor 
location, the proportion of the Parvimonas OTU was significantly higher in the descending colon and in the 
rectum (P < 0.001; Supplementary Fig. S3) than in other parts of the colon. Tumor stage and metastasis were not 
significantly correlated with the presence of specific bacteria. When the Fusobacterium OTU proportions were 
compared between cases and controls using Ct values, qPCR-positive cases showed higher OTU abundance 
values than qPCR-negative cases, and the significant positive correlation between these values is shown in Fig. 4.
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Discussion
CRC is a major health threat in many countries; however, its etiology and underlying mechanisms are still not 
comprehensively understood. The determination of a cancer’s etiology can result in the development of preven-
tive or therapeutic measures. Several studies have demonstrated enrichment of fecal or tissue samples of CRC 
patients with specific bacterial pathogens.
ETBF is a well-known pathogen of the gastrointestinal tract that can trigger a carcinogenic multistep process 
through B. fragilis  toxin3–5,20. However, we observed no significant difference in the prevalence of ETBF between 
CRC cases and controls, and its prevalence (35.9%) was significantly lower than that in a previous study (88.5%)20. 
Table 1.  Comparison of demographics and clinical characteristics of CRC patients and controls. NA not 
applicable. a One patient had two adenocarcinomas: one in the hepatic flexure and one in the rectum. b Four of 
the 12 controls with tubular adenoma had their tubular adenomas removed during colonoscopy.
Characteristic
Number (%) of patients
P-valueCases (n = 38) Controls (n = 21)
Age (years) 65.9 ± 10.8 63.6 ± 7.0 0.3440
Height (cm) 161.8 ± 8.6 160.7 ± 8.2 0.5200
Weight (kg) 60.1 ± 9.6 64.5 ± 11.5 0.1900
BMI 22.9 ± 2.9 24.8 ± 2.7 0.0150
Sex (F/M) 15/23 13/8 0.1120
Alcohol (drinker/nondrinker) 15/17 10/6 0.3680
Smoking (ever/never) 15/23 6/10 0.5330
Diabetes (yes/no) 31/8 5/2 0.6360
Hypertension (yes/no) 18/21 16/5 0.0310
Indication for colonoscopy; n (%)
Screening NA 21
Colorectal cancer 38 NA
Histologic diagnosis; n (%)
Hyperplastic polyp NA 1 (4.8)
Tubular adenoma NA 12 (57.1)b
Adenocarcinoma; n (%) 39a NA
Stage
 Stage I 4 (10.3) NA
 Stage II 9 (23.1) NA
 Stage III 12 (30.8) NA
 Stage IV 14 (35.9) NA
Location of CRC; n (%)
Cecum 1 (2.6) NA
Ascending colon 5 (12.8) NA
Hepatic flexure 4 (10.3) NA
Transverse colon 1 (2.6) NA
Descending colon 3 (7.7) NA
Rectosigmoid junction 2 (5.1) NA
Sigmoid colon 12 (30.8) NA
Rectum 11 (28.2) NA
Table 2.  Prevalence of CRC-associated bacteria by quantitative real-time PCR (qPCR). a No. of positives based 
on detection in the carcinoma tissues of CRC patients. b No. of positives based on detection in the left and/or 
right normal tissues of controls. c P-values were calculated using Fisher’s exact test.
Bacteria
No. (%) of patients positive for qPCR
P-valuecCRC patients (n = 39)a Controls (n = 21)b
Fusobacterium nucleatum 32 (82.1) 0 (0.0)  < 0.0001
colB + E. coli 15 (38.5) 4 (19.0) 0.1538
bft + Bacteroides fragilis 14 (35.9) 8 (38.1) 1.0000
Enterococcus faecalis 6 (15.4) 1 (4.8) 0.4037
Streptococcus gallolyticus 0 (0.0) 1 (4.8) 0.3500
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In a recent  study21, it was shown by qPCR that only 36.4% of CRC cases were positive for ETBF, and an equal 
distribution of B. fragilis was found in tumors, paired normal tissue and diverticula. Thus, the prevalence and 
distribution of ETBF should be determined by follow-up investigations. It has been shown that pathogenic E. 
coli can synthesize colibactin, which is  genotoxic22. The prevalence of colB + E. coli in CRC patients might be 
the link between E. coli and CRC. In our study, the prevalence of colB + E. coli in CRC cases was twice as high as 
that in controls, but the difference was not statistically significant, probably due to an insufficient sample size. 
S. gallolyticus and E. faecalis were also regarded as CRC-associated bacteria in previous  reports23,24; however, 
recent studies showed that the roles of S. gallolyticus and E. faecalis in CRC carcinogenesis were controversial due 
to their low  prevalence21,25,26. In our study, neither species was frequently detected in cancer patients (Table 2).
Figure 1.  F. nucleatum statuses of CRC patients and controls. (A) Patients with CRC were categorized 
according to tumor stage (I/II: early stage, III/IV: late stage). F. nucleatum prevalence was significantly higher 
in CRC patients at early and late stages than in controls (92% and 76.9% vs. 0%, respectively; Fisher’s exact 
test, P < 0.0001, each). (B) Tissues of CRC patients were collected from carcinoma tissues (CTs), adjacent 
normal tissues (ATs) and/or normal tissues (NTs) from non-CRC sites. F. nucleatum was significantly higher 
in CTs (82.1%) than in ATs (38.9%) and NTs (33.3%) of CRC patients (CT vs. AT, CT vs. NT, AT vs. T, and NT 
vs. T; Fisher’s exact test, P = 0.0002, < 0.0001, 0.0008, and 0.003, respectively) and was significantly higher in 
CTs than in tissues (Ts) of controls (P < 0.0001). (C) Comparison of the prevalence of the fadA gene revealed 
significant differences between the CTs of patients and tissues (Ts) of controls (69.2% vs. 9.5%; Fisher’s exact test, 
P < 0.0001). Four asterisks (****) indicate P < 0.0001, three asterisks (***) indicate P < 0.001, and two asterisks 
(**) indicate P < 0.001; Fisher’s exact test was performed using GraphPad Prism version 5.0 for Windows.
Figure 2.  Relative abundance of six OTUs that were significantly different between cases (CRC patients) and 
controls were compared using R software.
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In recent decades, F. nucleatum has attracted attention as a potential cause of CRC 4,6,27. The role of F. nuclea-
tum in CRC pathogenesis has not been comprehensively understood, but at least four mechanisms have been 
suggested to describe the  same28: (1) cell proliferation through Wnt signaling by an interaction between FadA and 
E-cadherin, (2) antitumor immune evasion via Fap2 and T cell immunoreceptors having Ig and immunoreceptor 
tyrosine-based inhibitory motif domains, (3) tumor binding and enrichment of Fap2 and Gal-GalNAc, and (4) 
chemoresistance by lipopolysaccharide and Toll-like receptor 4.
Fusobacterium species are strictly anaerobic and are difficult to isolate by culture. In this study, the prevalence 
of F. nucleatum in the tissues of CRC patients as tested by qPCR (82.1%) was notably higher than that obtained 
using anaerobic culture (7.7%; data not shown). Therefore, non-culture-dependent detection methods such as 
Table 3.  Differences in epidemiological characteristics with continuous values based on the association of 
CRC with the six OTUs. NA not applicable. *Statistically significant at P < 0.05.
Genus Relative abundance ≥ 1% Age BMI Tumor size CEA Total cholesterol
Fusobacterium
Positive 64.0 ± 10.5 22.7 ± 2.5 5.0 ± 2.4 236.8 ± 760.6 175.6 ± 43.9
Negative 73.1 ± 9.3 23.6 ± 4.2 5.2 ± 1.9 234.6 ± 458.7 172.6 ± 54.2
P-value 0.034* 0.609 0.883 0.992 0.890
Parvimonas
Positive 60.4 ± 8.5 22.4 ± 2.7 4.0 ± 1.8 512.5 ± 1118.3 182.8 ± 54.9
Negative 69.0 ± 10.9 23.2 ± 3.0 5.3 ± 2.3 92.7 ± 268.9 170.9 ± 40.4
P-value 0.011* 0.427 0.281 0.206 0.499
Gemella
Positive 63.2 ± 10.1 22.6 ± 2.4 4.4 ± 1.8 302.3 ± 540.4 173.2 ± 58.3
Negative 67.4 ± 11.1 23.1 ± 3.2 5.3 ± 2.4 202.0 ± 781.5 175.8 ± 38.5
P-value 0.240 0.606 0.403 0.646 0.886
Prevotella
Positive 65.4 ± 11.6 22.2 ± 1.9 5.3 ± 2.2 555.0 ± 1108.7 172.2 ± 45.4
Negative 66.2 ± 10.6 23.3 ± 3.3 4.9 ± 2.4 70.6 ± 249.3 176.4 ± 46.3
P-value 0.843 0.196 0.719 0.145 0.794
Peptostreptococcus
Positive 63.5 ± 11.9 23.0 ± 2.4 4.4 ± 1.4 524.9 ± 1177.6 169.6 ± 36.1
Negative 66.8 ± 10.5 22.9 ± 3.1 5.4 ± 2.5 118.7 ± 344.8 177.1 ± 49.2
P-value 0.434 0.896 0.283 0.285 0.609
Collinsella
Positive 65.8 ± 11.3 22.9 ± 3.0 NA 224.1 ± 714.0 171.9 ± 44.1
Negative 66.8 ± 5.3 22.7 ± 1.4 NA 340.5 ± 677.6 200.8 ± 55.9
P-value 0.780 0.774 NA 0.763 0.384
Table 4.  Differences in epidemiological characteristics with binomial values based on the association of CRC 









M F Yes No Yes No Yes No Yes No Left Right Yes No Yes No Yes No
Fusobacterium
Positive 18 12 7 23 13 17 14 11 15 15 6 24 11 18 9 7 8 5
Negative 5 3 1 7 2 6 1 6 5 3 4 4 4 4 0 4 2 1
P-value 0.999 0.660 0.440 0.088† 0.697 0.170 0.690 0.094† 0.999
Parvimonas
Positive 9 5 3 11 7 7 7 3 8 6 1 13 5 8 1 6 3 3
Negative 14 10 5 19 8 16 8 14 12 12 9 15 10 14 8 5 7 3
P-value 0.999 0.999 0.492 0.128 0.745 0.059† 0.999 0.070† 0.607
Gemella
Positive 8 5 2 11 6 7 8 5 8 5 2 11 6 6 2 5 4 3
Negative 15 10 6 19 9 16 7 12 12 13 8 17 9 16 7 6 6 3
P-value 0.999 0.689 0.728 0.280 0.506 0.441 0.488 0.374 0.999
Prevotella
Positive 6 6 3 9 4 8 6 3 7 5 3 9 7 5 2 5 3 3
Negative 17 9 5 21 11 15 9 14 13 13 7 19 8 17 7 6 7 3
P-value 0.481 0.689 0.728 0.243 0.734 0.999 0.164 0.374 0.607
Peptostreptococcus
Positive 7 4 2 9 5 6 5 4 6 5 2 9 5 6 1 4 4 1
Negative 16 11 6 21 10 17 10 13 14 13 8 19 10 16 8 7 6 5
P-value 0.999 0.999 0.722 0.699 0.999 0.690 0.728 0.319 0.588
Collinsella
Positive 21 13 7 27 14 20 13 16 16 18 10 24 14 19 8 10 10 5
Negative 2 2 1 3 1 3 2 1 4 0 0 4 1 3 1 1 0 1
P-value 0.999 0.999 0.999 0.589 0.107 0.556 0.633 0.999 0.375
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qPCR or 16S rRNA analysis may be essential for screening Fusobacterium species or for studying its epidemiol-
ogy in a population during the development of CRC.
The presence of F. nucleatum was significantly correlated with both the early and late stages of CRC (Fig. 1A). 
This finding suggests that F. nucleatum may be involved in CRC carcinogenesis from an early stage, and one 
review indicated an association of F. nucleatum with carcinomas throughout the different stages of CRC 
 progression29. Analysis of the abundance of F. nucleatum by tissue type showed that the bacteria seemed to be 
more prevalent in CTs than in ATs and NTs (Fig. 1B). This finding is consistent with previous studies showing 
that a high level of Fusobacterium colonization is associated with CRC 27,30.
Figure 3.  Differences in the proportion of Fusobacterium between heavy drinkers and non/light drinkers by 
cases (CRC patients) and controls. The proportion of Fusobacterium OTUs was significantly higher in heavy 
drinkers than in non/light drinkers (P = 0.003); no corresponding pattern was observed in controls. We used R 
software to perform the comparison and generate the figure.
Figure 4.  Box and whisker plots of the relative abundance of Fusobacterium by 16S rRNA analysis based on 
F. nucleatum qPCR positivity. Relative abundance (expressed as OTU percentages) was log-transformed for 
plotting on the Y-axis. Analysis was conducted with R software.
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FadA is a well-known oncogenic virulence factor that can induce oncogenic gene expression and promote 
the growth of CRC  cells6. Therefore, FadA is regarded as a major virulence factor of F. nucleatum in CRC, and 
69.2% of CT samples were positive for the fadA gene. However, some discrepancies between F. nucleatum pres-
ence and fadA gene frequency were observed in our study (Fig. 1C). Thus, it may be necessary to evaluate both 
F. nucleatum presence and fadA gene frequency to accurately determine the presence and virulence of F. nuclea-
tum31. Interestingly, a recent study suggested that the fadA gene is not specific to F. nucleatum and that it is also 
present in other Fusobacterium  species32. This finding indicates the need for further research regarding the role 
of other Fusobacterium species in CRC carcinogenesis.
The gut microbiome comprises numerous bacterial species that interact with each other, and it is possible 
that other bacteria in addition to the five known CRC-associated bacteria that were examined in the present 
study may affect the carcinogenesis of CRC. Thus, CRC metagenomic analysis is now commonly used to analyze 
this complex bacterial community. According to our 16S rRNA analysis, six genera, namely, Peptostreptococcus, 
Collinsella, Prevotella, Parvimonas, Gemella, and Fusobacterium were significantly abundant in CRC patients. 
Kwong et al. reported that P. anaerobius promoted CRC carcinogenesis in  ApcMin/+ mouse models, and a cor-
relation between Peptostreptococcus species and human CRC was reported  previously33. The role of Collinsella 
species in CRC has rarely been investigated; however, Ai et al. reported that Collinsella species were specifically 
correlated with CRC in the Chinese population using metagenomic  analysis34. The association of Prevotella spe-
cies with CRC was reported in a previous  study35, and our results are compatible with this report. Parvimonas and 
Gemella species were also reported as potential causative agents that may be responsible for CRC  carcinogenesis36. 
However, it is difficult to determine which bacteria are the primary cause of CRC, as the gut microbiome is too 
complex and can vary by  population37.
Based on an integrated analysis of 16S rRNA data and epidemiologic characteristics, we found a marginally 
significant correlation between Fusobacterium occurrence and a history of alcohol consumption. It has been 
shown that alcohol consumption is one of the major contributors to CRC  carcinogenesis38. The generation of 
acetaldehyde and other metabolites from alcohol activates cancer-promoting  signals39. Moreover, it was sug-
gested that ethanol oxidation by intestinal anaerobes, including Fusobacterium species, under aerobic conditions 
in the colon and rectum may also play an important role in the pathogenesis of ethanol-related CRC 40. To our 
knowledge, the present study was the first to determine the relationship between alcohol consumption and the 
presence of Fusobacterium using 16S rRNA analysis. In the integrated statistical analysis, a cutoff of 1% was used 
to determine the positivity of each  OTU41. It is interesting to note that 87.5% (28/32) of qPCR-positive cases and 
76.2% (16/21) of qPCR-negative controls showed the same 16S rRNA analysis results when a cutoff of 1% was 
used. This cutoff seems to be the appropriate threshold to determine abundance in 16S rRNA analysis in CRC 
tissues, though more investigations are required to confirm the cutoff.
The limitations of this study were the relatively small sample size, which was associated with low statisti-
cal significance, and the fact that tubular adenoma could not be analyzed as an independent group due to the 
small sample size. However, the simultaneous analysis of the presence of specific bacterial pathogens, 16S rRNA 
analysis, patient demographics and clinical characteristics may be an advantage of this study. The detection of F. 
nucleatum in stool can be helpful for diagnosing CRC in patients as a biological tumor marker if used concur-
rently with other tumor markers, and an appropriate testing method should be developed and validated.
In conclusion, F. nucleatum was significantly prevalent in the CTs of patients with CRC and frequently present 
in both early and late stages. These data support that this bacterium is strongly associated with the development 
of CRC. The correlation between alcohol consumption and the abundance of Fusobacterium OTUs in cancer 
tissue discovered using 16S rRNA analysis suggests a possible link between alcohol metabolism and changes in 
the gut microbiome and subsequent tumorigenesis caused by F. nucleatum.
Methods
Study population. A total of 38 CRC patients and 21 controls who were diagnosed using colonoscopy at 
a tertiary-care hospital between June 2015 and November 2016 were enrolled. Patients who received preopera-
tive radiation, chemotherapy, and/or antibiotic treatment within 4 weeks were excluded. One patient had two 
primary adenocarcinoma lesions; thus, 39 CRC samples were analyzed in this study. Among the 21 controls, 12 
individuals had tubular adenomas removed during colonoscopy, and 9 individuals showed no specific findings 
in colonoscopy. Patients with tubular adenomas were analyzed as controls because most of the polyps could be 
regarded as low risk due to their pathologic findings and small size (< 10 mm), and the resection margin was 
clear in all samples. G* power 3.1.9.7 analysis was conducted using the chi-square test to justify the appropriate 
sample size, and the test showed a significance level of 0.05 and a power of 0.81. Patient demographics and clini-
cal characteristics were investigated by reviewing the medical records and interviews. Total alcohol consump-
tion was calculated based on the history of alcohol intake—determined based on factors such as beverage type, 
amount, and frequency of consumption—and patients were classified as non/light drinkers (0‒1 drink/day) 
or heavy drinkers (≥ 2 drinks/day). All patients were classified as smokers (persons who are/were smokers) or 
nonsmokers (persons who never smoked) based on their smoking history.
Ethics approval and consent to participate. This study was approved by the Institutional Review Board 
at Severance Hospital, Yonsei University, Republic of Korea (approval number: 2014-2768-004). All methods 
were performed following the relevant guidelines and regulations. Documented informed consent was obtained 
from each study participant.
Colon tissue collection. Colonoscopy biopsies were obtained from the carcinoma tissues (CTs), adjacent 
normal tissues (ATs), and/or distant normal tissues (DTs) of CRC patients and from the right (from the cecum 
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to transverse) and left (from descending to the rectum) colons of controls. Tissue samples were categorized as 
’normal tissue’ (NT) if no macroscopic or pathological evidence of carcinoma was observed. Tissue biopsies were 
collected in Transystem tubes (Copan, Brescia, Italy) containing anaerobic transport medium. Culture and DNA 
extraction for qPCR were performed within 30 min after tissue collection, and the remaining tissues were stored 
in a deep freezer (− 70 ℃) for 16S rRNA analysis. Detailed characteristics of CRC patients and controls are sum-
marized in Supplementary Tables S1A,B.
Detection of CRC‑associated bacteria using qPCR. DNA was directly extracted from colon tissue 
using the QIAamp DNA Micro Kit (QIAGEN, Hilden, Germany) according to the manufacturer’s instructions. 
DNA concentration and purity were recorded using a NanoDrop spectrophotometer (NanoDrop Technologies, 
Montchanin, U.S.A.). The specific 16S ribosomal RNA (rRNA) genes were amplified by qPCR using the CFX96 
Real-Time PCR System (Bio-Rad, Hercules, CA) to detect five CRC-associated bacteria:  ETBF42, colB + E. coli43, 
E. faecalis44, F. nucleatum27, and S. gallolyticus45. The reaction mixture consisted of 10 µL of Ex Taq (TaKaRa, 
Kusatsu, Japan), 0.4 µL of each specific primer pair (10 µM), and 25 ng/µL DNA template in a total reaction 
volume of 20 µL. E. faecalis ATCC 29212, F. nucleatum subsp. nucleatum ATCC 25586 and three clinical isolates 
(ETBF, colB + E. coli and S. gallolyticus) were used for qPCR quality control. Identification of the clinical isolate 
was performed using MALDI-TOF mass spectrometry and 16S rRNA sequencing. For S. gallolyticus, the rpoB 
gene was also sequenced. The presence of the fadA gene in F. nucleatum was determined using the conventional 
PCR method in accordance with a previous  study31, and the 211  bp size of the amplicon was confirmed by 
sequencing.
16S rRNA analysis. The V3 and V4 regions of the 16S rRNA gene (400–450 bp) were PCR amplified using 
target-specific primers and adapters for Illumina sequencing. Next-generation sequencing was performed on 
a MiSeq platform (Illumina, San Diego, USA) using the MiSeq Reagent Kit V2 with 500 cycles. Paired-end 
sequences were merged using PANDASEQ  software46, and clustering of operational taxonomic units (OTUs) 
and taxonomy assignment were performed using QIIME  software19. The observed diversity and Chao1 and 
Shannon indexes for α-diversity were calculated using QIIME. Principal components were calculated and plot-
ted for β-diversity estimation. The relative proportion of each OTU was compared between cases and controls 
as well as with respect to epidemiological characteristics. OTUs present in > 1% of all OTUs were regarded as 
 positive16. The mock community was analyzed before clinical specimen testing to validate the 16S rRNA analysis 
results.
Statistical analyses. For 16S rRNA analysis, correction for multiple testing was performed using the false 
discovery rate (FDR) method. All statistical analyses were performed using GraphPad Prism version 5.0 (https 
://www.graph pad.com/scien tific -softw are/prism /, GraphPad Software, La Jolla, CA, USA; Tables 1, 2, Fig. 1) and 
R software (https ://www.R-proje ct.org, The R Foundation, version 3.5.3; Tables 3, 4, Figs. 2, 3, 4)47. A value of 
P < 0.05 was defined as statistically significant, and a P-value between 0.05 and 0.10 was considered marginally 
significant.
Data availability
The datasets generated and/or analyzed during the current study are available from the corresponding author 
upon reasonable request.
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